NewsRx

Search our medical news database

Liver Cancer

Survival Rates Low After Surgery For Hepatocellular Carcinoma Recurrence

Published in Hepatitis Weekly, April 9th, 2001

by Sonia Nichols, staff medical writer - Disease-free survival rate in patients treated for liver cancer recurrence is low, according to medical researchers at Japan's Nara Medical University.

Japan and other countries in Asia experience elevated rates of hepatocellular carcinoma (HCC), a primary form of liver cancer, due to the prevalence of hepatitis viruses B and C. Surgical and non-surgical ablative therapies are used for treating second occurrences of liver cancer after primary treatments. However, new research shows second surgeries for cancer recurrence is associated with a lower rate of disease-free survival in patients in Japan.

The...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook